Begin main content

Reports

We found 5993 result(s)

dapagliflozin (Forxiga )

Last Updated: April 8, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: dapagliflozin
Indications: Heart failure with reduced ejection fraction

  • Brand Name: Forxiga
  • Manufacturer: AstraZeneca Canada Inc.
  • Project Number: SR0642-000
  • Project Status: Received
  • Submission Type: New

ixekizumab (Taltz )

Last Updated: April 7, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: ixekizumab
Indications: Ankylosing spondylitis

  • Brand Name: Taltz
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: SR0630-000
  • Project Status: Active
  • Submission Type: New Indication

Iron (III) Isomaltoside 1000 (Monoferric)

Last Updated: April 9, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Iron (III) Isomaltoside 1000
Indications: iron deficiency anemia

  • Brand Name: Monoferric
  • Manufacturer: Pharmacosmos A/S
  • Project Number: SR0622-000
  • Project Status: Active
  • Submission Type: New

tafamidis (Vyndaqel)

Last Updated: April 8, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: tafamidis
Indications: transthyretin-mediated amyloidosis

  • Brand Name: Vyndaqel
  • Manufacturer: Pfizer Canada
  • Project Number: SR0625-000
  • Project Status: Complete
  • Submission Type: New

vortioxetine hydrobromide (Trintellix )

Last Updated: April 8, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: vortioxetine hydrobromide
Indications: Major depressive disorder (MDD), adults.

  • Brand Name: Trintellix
  • Manufacturer: Lundbeck Canada Inc.
  • Project Number: SR0611-000
  • Project Status: Complete
  • Submission Type: New

safinamide (Onstryv)

Last Updated: April 6, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: safinamide
Indications: Parkinson's disease

  • Brand Name: Onstryv
  • Manufacturer: Valeo Pharma Inc.
  • Project Number: SR0617-000
  • Project Status: Active
  • Submission Type: New

erenumab (Aimovig)

Last Updated: April 8, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: erenumab
Indications: Migraine

  • Brand Name: Aimovig
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0578-000
  • Project Status: Active
  • Submission Type: New

New at CADTH - April 2020

Last Updated: April 9, 2020
Result type: Reports
Product Line: New at CADTH

News and Events CADTH is committed to serving you during the COVID-19 crisis. If you’re looking for credible answers to your COVID-19 questions, CADTH can help. We have created a website where you’ll find information from CADTH and other respected organizations related to COVID-19. As the COVID-19 situation is changing daily, we’ll be updating ...